2025年1月8日 · REVATIO is a phosphodiesterase-5 (PDE-5) inhibitor indicated for the treatment of pulmonary arterial hypertension (PAH) (World Health Organization [WHO] Group I) in adults to improve exercise ability and delay clinical worsening. (1) Adults: 20 mg orally three times a day. Dose may be increased based on symptoms and tolerability. (2.1)

2009年11月19日 · Revatio is the only FDA-approved phosphodiesterase-5 (PDE5) inhibitor available in both tablet and intravenous formulations. Revatio is indicated for the treatment of adult patients with pulmonary arterial hypertension (WHO Group I) to improve exercise ability and delay clinical worsening.

REVATIO injection is for the continued treatment of patients with PAH who are currently prescribed oral REVATIO and who are temporarily unable to take oral medication. The recommended dose is 2.5 mg or 10 mg administered as an …

2024年12月10日 · Revatio relaxes muscles of the blood vessels and increases blood flow to particular areas of the body. Revatio is used to treat pulmonary arterial hypertension and improve exercise capacity in men and women. Sildenafil under the name Viagra is used to treat erectile dysfunction (impotence) in men.

REVATIO is a phosphodiesterase-5 (PDE-5) inhibitor indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group I) in adults to improve exercise ability and delay …

Indicated for treatment of pulmonary arterial hypertension (PAH) (World Health Organization [WHO] Group I) to improve exercise ability and delay clinical worsening. Revatio (PO), Liqrev: 20 mg PO...

2024年1月3日 · It is used to treat high blood pressure in the lungs. It may be given to you for other reasons. Talk with the doctor. What do I need to tell my doctor BEFORE I take Revatio Injection? If you have an allergy to sildenafil or any other part of Revatio Injection (sildenafil injection (PAH)).

2014年6月26日 · Revatio is a medicine used to treat adults and children from 1 year of age with pulmonary arterial hypertension (PAH, abnormally high blood pressure in the arteries of the lungs). In adults, Revatio is used in patients with class II (slight limitation of physical activity) or class III (marked limitation of physical activity) PAH.

2023年1月27日 · REVATIO is indicated in pediatric patients 1 to 17 years old for the treatment of pulmonary arterial hypertension (PAH) (WHO Group I) to improve exercise ability and, in pediatric patients too young to perform standardized exercise testing, pulmonary hemodynamics thought to underlie improvements in exercise [see Clinical Studies (14)].

Revatio (oral) is indicated for treatment of adult patients with pulmonary arterial hypertension classified as WHO functional class II and III, to improve exercise capacity. Efficacy has been shown in primary pulmonary hypertension and pulmonary hypertension associated with connective tissue disease.